ArQule Message Board - Msg: 4683683

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (216)	6/2/1998 9:37:00 AM
From: Dr. John M. de Castro	Read Replies (2) of 399

The GENE collaboration has a new twist. If I read the release correctly, ARQL will not only be supplying the chemicals but will also be doing the screening. The release refers to ARQL's advanced screening capabilities. I wasn't even aware that ARQL was in the screening business. Interesting! John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next